Senior Vice President, Late-Stage Clinical Development
Revolution Medicines - Redwood City, California, United States
Posted Nov 6, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- $419K-$523K From the posting source checked Nov 18, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $81,444 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +6.9% - Faster than average
478% above the BLS role benchmark for healthcare aggregate.
Posted salary is far from this role benchmark; treat it as low confidence.
Matched to SOC 29-1141 - Healthcare aggregate by role bucket.
Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 18, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Senior Vice President, Late-Stage Clinical Development Redwood City, California, United States Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide. Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor-all in service of patients. The Opportunity: The Senior Vice President, Late-Stage Clinical Development is one of the most visible and influential leadership roles in the company. Reporting to the Chief Medical Officer and sitting at the top of the late-stage clinical development organization, this executive plays a key role in shaping how the portfolio evolves. The person in this seat drives the future value of the company from a compound perspective. The role arrives at an inflection point. With the first medicine approved and multiple registrational programs running in parallel, the company is moving from a single approved product to a multi-asset, multi-indication late-stage portfolio. This leader drives the overall clinical development strategy, maps out the plan that carries the portfolio forward in partnership with the Chief Medical Officer, and owns the registrational and
Read the full description at www.revmed.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Vice President, Head of Transactions and Partnering
Revolution Medicines - Redwood City, California, United States
Senior Vice President, Medical Affairs
Tango Therapeutics Inc - Boston, MA
Vice President, Clinical Development
Beam Therapeutics Inc - Cambridge, MA
Vice President Clinical Development #4979
Grail Inc - Sunnyvale, CA